1. Nadia S, Jumat S, Emad Y. Synthesis and antimicrobial activities of 9H-carbazole derivatives. ARAB J CHEM. 2016; 9(1): S781-S786. [
DOI:10.1016/j.arabjc.2011.08.013]
2. Suresh M, Lavanya P, Sudhakar D, Vasu K, Venkata Rao C. Synthesis and biological activity of 8-chloro-(1,2,4)triazolo(4,3-a)quinoxalines. J Chem Pharm Res. 2010; 2: 497-504.
3. Popiołek Ł, Kosikowska U, MazurL, Dobosz M, Malm A. Synthesis and antimicrobial evaluation of some novel 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Med Chem Res. 2013; 22(7): 3134-3147. DOI 10.1007/s00044-012-0302-9. [
DOI:10.1007/s00044-012-0302-9]
4. El-Sawy ER1, Bassyouni FA, Abu-Bakr SH, Rady HM, Abdlla MM, Synthesis and biological activity of some new 1-benzyl and 1-benzoyl-3-heterocyclic indole derivatives, Acta Pharm. 2010; 60(1):55-71. doi: 10.2478/v10007-010-0004-0. [
DOI:10.2478/v10007-010-0004-0]
5. H Washton. Review of fluconazole: A new triazole antifungal agent. Diagnostic Microbiology and Infectious Disease. 1989; 12(4): 229-233: doi.org/10.1016/0732-8893(89)90141-7. [
DOI:10.1016/0732-8893(89)90141-7]
6. Moreno E, Ancizu S, Pérez-Silanes S, Torres E, Aldana I, Monge A. Synthesis and Antimycobacterial Activity of New Quinoxaline-2-Carboxamide 1,4-di-N- Oxide Derivatives. Eur J Med Chem. 2010; 45(10): 4418-26. doi: 10.1016/j.ejmech.2010.06.036. [
DOI:10.1016/j.ejmech.2010.06.036]
7. Yurttaş L, Ertaş M, Cankılıç MY, Demirayak Ş. Synthesis and Antimycobacterial Activity Evaluation of Isatin-derived 3- ((4- aryl - 2- thiazolyl))hydrazone)-1H- indol- 2, 3- diones. Acta Pharm. Sci. 2017; 55(1): 51-58. DOI: 10.23893/1307-2080.APS.0554. [
DOI:10.23893/1307-2080.APS.0554]
8. Petronijevic j, Bugarčić ZM, Janković N. Synthesis of Quinoxaline-Based Compounds and Their Antitumor and Antiviral Potentials. Mini-Reviews in Organic Chemistry. 2017; 14(3): DOI: 10.2174/1570193X14666171201143357. [
DOI:10.2174/1570193X14666171201143357]
9. El-Sayed WA, Khalaf HS, Mohamed SF, Hussien HA, Kutkat OM, Amr AE. Synthesis and Antiviral Activity of 1,2,3-Triazole Glycosides Based Substituted Pyridine via Click Cycloaddition. Russ. J Gen Chem. 2017; 87: 2444-2453. DOI:10.1134/S1070363217100279. [
DOI:10.1134/S1070363217100279]
10. Burguete A, Pontiki E, Hadjipavlou-Litina D, Ancizu S, Villar R, Solano B, et al. Synthesis and biological evaluation of new quinoxaline derivatives as antioxidant and anti-inflammatory agents. Chem Biol Drug Des. 2011; 77: 255-67. doi: 10.1111/j.1747-0285.2011.01076.x. [
DOI:10.1111/j.1747-0285.2011.01076.x]
11. Mahaney PE, Webb MB, Ye F, Sabatucci JP, Steffan RJ. Synthesis and activity of a new class of pathway-selective estrogen receptor ligands: hydroxybenzoyl-3,4-dihydroquinoxalin-2(1H)-ones. Bioorg Med Chem. 2006; 14: 3455-3466. [
DOI:10.1016/j.bmc.2006.01.001]
12. Rangisetty JB, Gupta CNVHB, Prasad AL, Srinivas P, Sridhar N, Parimoo P, et al. Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice. J Pharm Pharmacol. 2001; 53: 1409-1413. DOI:10.1211/002235701177776. [
DOI:10.1211/0022357011777765]
13. Rajasekaran A, Rajagopal KA. Rajagopal:Synthesis of some novel triazole derivatives as anti-nociceptive and anti-inflammatory agents. Acta Pharm. 2009; 59(3): 355-64. doi: 10.2478/v10007-009-0026-7. [
DOI:10.2478/v10007-009-0026-7]
14. Guillon J, Cohen A, Gueddouda NM, Das RN, Moreau S, Ronga L. Design, synthesis and antimalarial activity of novel bis{N-((pyrrolo(1,2-a)quinoxalin-4-yl)benzyl)-3-aminopropyl}amine derivatives. J Enzyme Inhib Med Chem. 2017; 32(1): 547-563. doi: 10.1080/14756366.2016.1268608. [
DOI:10.1080/14756366.2016.1268608]
15. Manohar S, Khan SI, Rawat DS. Synthesis of 4‐aminoquinoline‐1,2,3‐triazole and 4‐aminoquinoline‐1,2,3‐triazole‐1,3,5‐triazine Hybrids as Potential Antim alarial Agents. Chem Biol Drug Des. 2011; 78(1): 124-36. doi: 10.1111/j.1747-0285.2011.01115.x.. [
DOI:10.1111/j.1747-0285.2011.01115.x]
16. Miri Mahmoody, Jabbar Khalafy, Mehdi M. Baradarani. A study of the synthesis and nonlinear optical properties of 3-substituted 5H-(1,2,4)triazolo(3',4':2,3) (1,3,4)thiadiazino(5,6-b)quinoxaline derivatives. Chemistry Today. 2017; 35: 44-47.
17. El-Attar MAZ, Shaaban OG, Elbayaa RY, Habib NS, El-Hawash SAM, Wahab AEA. Design and Synthesis of Some New 1,2,4-Triazolo(4,3a )Quinoxaline Derivatives as Potential Antimicrobialagents. Med chem. 2015; 5: 489-495. Doi:10.4172/2161-0444.1000307. [
DOI:10.4172/2161-0444.1000307]
18. Cheruiyot KR, Olila D, Kateregga J. In-vitro antibacterial activity of selected medicinal plants from Longisa region of Bomet district, Kenya. Afr Health Sci. 2009; 9(1): S42-S46.
19. Magaldi S, Mata-Essayag S, Hartung de Capriles C, Perez C, Colella MT, Olaizola C, et al. Well diffusion for antifungal susceptibility testing. Int J Infect Dis. 2004; 8:39-45. doi:10.1016/j.ijid.2003.03.002. [
DOI:10.1016/j.ijid.2003.03.002]
20. Moses I, Maduagwu U, Osazuwa E. Evaluation of the Antifungal Activity of Aqueous and Alcoholic Extracts of Six Spices. Am J Plant Sci. 2016; 7(1): 118-125. DOI: 10.4236/ajps.2016.71013. [
DOI:10.4236/ajps.2016.71013]
21. Gopi R, Senthil S. Quinoline appended 1, 2, 3-triazole analogues: Synthesis, antimicrobial and docking evaluation. Int J Chem Stud. 2017; 5(1): 208-216.
22. Mishra R, Kumar S, Kumar R, Majeed J. Synthesis and in vitro antimicrobial activity of some triazole derivatives. Chem Soc.2010; 55(3): 359-362. [
DOI:10.4067/S0717-97072010000300019]
23. Khalafy J, Mohammadlou M, Mahmoody M, Salami F, Marjani AP. Facile synthesis of new 10-substituted-5H-naphtho (1, 2-e)(1, 2, 4) triazolo (3, 4-b)(1, 3, 4) thiadiazin-5-ones. Tetrahedron Letters. 2015; 56: 1528-1530. [
DOI:10.1016/j.tetlet.2015.02.002]